YORLANI Trademark

Trademark Overview


On Thursday, September 28, 2023, a trademark application was filed for YORLANI with the United States Patent and Trademark Office. The USPTO has given the YORLANI trademark a serial number of 98202588. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 29, 2025. This trademark is owned by Pfizer Inc.. The YORLANI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
yorlani

General Information


Serial Number98202588
Word MarkYORLANI
Filing DateThursday, September 28, 2023
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 2, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Trademark Events


Event DateEvent Description
Monday, October 2, 2023NEW APPLICATION ENTERED
Tuesday, May 21, 2024ASSIGNED TO EXAMINER
Thursday, October 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 28, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 12, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 26, 2025SOU TEAS EXTENSION RECEIVED
Thursday, February 27, 2025SOU EXTENSION 1 GRANTED
Thursday, February 27, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 29, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, September 29, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, February 26, 2025SOU EXTENSION 1 FILED